Article Commentary: The Role of Adjuvant Therapy in Gastrointestinal stromal Tumor after Operative Treatment
Clinical Medicine. Gastroenterology · 2009
DOI: 10.4137/cgast.s3422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine. Gastroenterology, 2009. Verfasst von Ka-Ho Lok. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed.
Zitieren
APA
Lok, K. (2009). Article Commentary: The Role of Adjuvant Therapy in Gastrointestinal stromal Tumor after Operative Treatment. Clinical Medicine. Gastroenterology. https://doi.org/10.4137/cgast.s3422
Vancouver
Lok K. Article Commentary: The Role of Adjuvant Therapy in Gastrointestinal stromal Tumor after Operative Treatment. Clinical Medicine. Gastroenterology. 2009. doi:10.4137/cgast.s3422
BibTeX
@article{Lok2009,
author = {Lok, Ka-Ho},
title = {Article Commentary: The Role of Adjuvant Therapy in Gastrointestinal stromal Tumor after Operative Treatment},
journal = {Clinical Medicine. Gastroenterology},
year = {2009},
doi = {10.4137/cgast.s3422}
}
EUVIMED